1st Quarter - Report

TCH GROUP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

S.Con.Res.11-An original concurrent resolution setting forth the congressional budget for the United States government for fiscal year 2016.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 11 (114th)

Health Issues HCR

General heath care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative regulatory issues. 340B Drug Discount Program

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3590 (114th)

Medicare/Medicaid MMM

Medicare Part D issues. S.31 Medicare Prescription Drug Price Negotiation Act- Provisions related to Part D program. S.141 Protecting Seniors Access to Medicare Act of 2015. H.R. 1470 SGR Repeal and Medicare Provider Payment Modernization Act of 2015.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 141 (114th), H.R. 1470 (114th), S. 31 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.